Can a shorter, oral combo tame early HER2-Positive breast cancer?
NCT ID NCT04383275
First seen Aug 19, 2026 ยท Last updated Aug 19, 2026
Summary
This trial is testing whether combining the targeted drug trastuzumab with either oral chemotherapy or hormone therapy can effectively treat stage I HER2-positive breast cancer. The study includes women aged 18-70 with small, lymph-node-negative tumors, divided into two groups based on hormone receptor status. The goal is to see if this approach can keep the cancer from coming back while potentially offering a more convenient treatment option.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- trastuzumab combined with capecitabine or endocrine therapy
- What this could lead to
- If successful, this could offer a less intensive, oral-based treatment option for early-stage HER2-positive breast cancer, potentially reducing recurrence while maintaining quality of life.
- What could go wrong
- This is a phase II trial, so results are preliminary. The combination may not improve outcomes over standard care, and side effects like heart toxicity or gastrointestinal issues could occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Breast cancer institute of Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple search strategy boost breast cancer detection?
- Can a new infusion drug shrink Hard-to-Treat breast tumors?
- AI vs. PDFs: which tool helps future doctors pick the right cancer treatment?
- Can a new PET tracer spot breast cancer spread better than standard scans?
- A good Night's sleep for cancer patients? video therapy put to the test
- Can freezing breast tumors replace the scalpel?